Efficacy of Adalimumab Therapy in Patients with Crohn's Disease Who Were Unresponsive to or Intolerant of Infliximab: Six Years of Experience in a Single Gastroenterology Center

被引：1
|
作者：
Shafran, Ira [1 ]
Cangemi, David [1 ]
Burgunder, Patricia [1 ]
机构：
[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-01212
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1212
引用
收藏
页码：S444 / S444
页数：1
相关论文
共 50 条
  • [21] Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine mercaptopurine
    Wahed, M.
    Louis-Auguste, J. R.
    Baxter, L. M.
    Limdi, J. K.
    McCartney, S. A.
    Lindsay, J. O.
    Bloom, S. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (06) : 614 - 620
  • [22] Comparative efficacy of Infliximab, Adalimumab, and Ustekinumab in patients with biologics naive Crohn's disease:a retrospective observational single-center study
    Sakurai, K.
    Takahashi, S.
    Fujihata, K.
    Watanabe, R.
    Nishimura, Y.
    Yamada, R.
    Sawada, K.
    Sano, I.
    Oda, H.
    Miyagishima, T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1271 - I1271
  • [23] Comparison of infliximab with adalimumab in biologic-naive patients with Crohn's disease: a single-center 13-year experience
    Erdogan, C.
    Durak, M. B.
    Alkan, A.
    Kilic, V.
    Kivrakoglu, F.
    Kosar, K.
    Yuksel, I.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (12) : 5757 - 5766
  • [24] Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience
    Olivera, Pablo
    Thiriet, Linda
    Luc, Amandine
    Baumann, Cedric
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (06) : 976 - 985
  • [25] Safety of Infliximab in Crohn's Disease: A Large Single-center Experience
    Hamzaoglu, H.
    Cooper, J.
    Alsahli, M.
    Falchuk, K. R.
    Peppercorn, M. A.
    Farrell, R. J.
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (12) : 2109 - 2116
  • [26] Infliximab therapy for Crohn's disease: The Crohn's and colitis center of New Jersey experience.
    Botros, N
    Griffel, LH
    Kosa, EM
    Prasad, S
    Das, KM
    GASTROENTEROLOGY, 2000, 118 (04) : A1334 - A1334
  • [27] Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: A large single centre experience
    Sprakes, Michael B.
    Ford, Alexander C.
    Warren, Lisa
    Greer, Dan
    Hamlin, John
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (02): : 143 - 153
  • [28] Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study
    Song, Won Jae
    Kang, Ben
    Choi, So Yoon
    Choe, Yon Ho
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2016, 19 (02) : 116 - 122
  • [29] Adalimumab in the Treatment of Active Luminal and Perianal Crohn's Disease: A Single Center Experience in 100 Patients
    Rizzello, Fernando
    Gionchetti, Paolo
    Tambasco, Rosy
    Brugnera, Ramona
    Straforini, Giulia
    Calabrese, Carlo
    Campieri, Massimo
    GASTROENTEROLOGY, 2009, 136 (05) : A177 - A177
  • [30] Clinical experience with infliximab therapy in 100 patients with Crohn's disease
    Farrell, RJ
    Shah, SA
    Lodhavia, PJ
    Alsahli, M
    Falchuk, KR
    Michetti, P
    Peppercorn, MA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (12): : 3490 - 3497
12345